Jeffrey Yu Increases Stake in OneMedNet Corporation
Chief Medical Officer Jeffrey Yu purchased 172,414 shares of OneMedNet at $0.58 per share.
Key Points
- Jeffrey Yu, OneMedNet's Chief Medical Officer, bought 172,414 shares at $0.58 each on June 16, 2026.
- OneMedNet Corporation, trading on NasdaqCM under ONMD, has a market cap of about $27.3 million.
- Other insiders also acquired shares in June, including CEO Aaron Green and Thomas Kosasa.
In a recent insider transaction, Jeffrey Yu, the Chief Medical Officer of OneMedNet Corporation, purchased 172,414 shares of the company. The shares were bought at $0.58 each, amounting to a total investment of approximately $100,000. This purchase took place on June 16, 2026, and was not part of a pre-arranged trading plan.
Insider Buying and Selling at OneMedNet Corporation
Jeffrey Yu wasn't the only insider buying shares of OneMedNet recently. CEO Aaron Green also increased his holdings, purchasing 18,702 shares at $0.54 on June 15 and an additional 36,920 shares at $0.56 on June 12. Thomas Kosasa, another insider, was active as well, buying 158,730 shares at $0.63 on June 12, and earlier, 268,817 shares at $0.93 on May 18.
Other Institutional Activity in OneMedNet Corporation
Several institutional investors have also been adjusting their positions in OneMedNet. Exencial Wealth Advisors, LLC significantly boosted its holdings by 4,732,698 shares, bringing its total to 8,377,559 shares valued at approximately $7.12 million. Vanguard Capital Management LLC added 1,115,565 shares, ending with the same number of shares worth about $948,230. Geode Capital Management, LLC increased its stake by 41,802 shares, totaling 338,528 shares valued at $287,782. Meanwhile, Vanguard Fiduciary Trust Co and Citigroup Inc both took new positions, each holding 136,613 and 135,445 shares, respectively.
OneMedNet Corporation Stock Snapshot
Shares of OneMedNet Corporation (NasdaqCM: ONMD) recently traded near $0.501. The company has a market capitalization of about $27.3 million and a beta of 1.122, indicating moderate volatility compared to the market. The stock's 52-week range has seen a low of $0.333 and a high of $4.22. OneMedNet's 50-day moving average is $0.86048, and its 200-day moving average is $1.151295.
Recent Earnings
OneMedNet reported revenue of $1.318 million, though it experienced a revenue decline of 29.9%. The company has a negative net margin of -254.325%, reflecting ongoing financial challenges. With an EPS of -$0.04, OneMedNet does not have a meaningful P/E ratio due to its lack of profitability.
About OneMedNet Corporation
OneMedNet Corporation is a healthcare software company based in Eden Prairie, Minnesota. It specializes in digital medical image management, exchange, and sharing solutions across the Americas, Europe, and the Middle East. The company offers products like iRWD, which provides regulatory-grade imaging and clinical data for pharmaceutical and device manufacturing markets, and BEAM, a platform for medical imaging exchange between different healthcare entities. Led by CEO Aaron Green, OneMedNet operates with a small team of 22 employees.
Bottom Line
Jeffrey Yu's recent purchase of OneMedNet shares highlights insider confidence in the company's potential. Investors often track insider transactions like these for insights into the company's prospects. It's important to note that such transactions are disclosed after they occur and may not reflect current positions. OneMedNet's stock remains volatile, with a market cap of around $27.3 million and significant insider and institutional activity.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.